Amgen, a global biotechnology leader highlighting profound research and development capabilities and biomanufacturing, showcases its latest achievements in the field of innovative medicines under the ...

However, sports and medicine have changed dramatically since the era of doping tragedies such as Tom Simpson. Most recent ...

(Reuters) - Amgen (NASDAQ: AMGN) reported higher quarterly earnings on Wednesday, driven by a 24% rise in sales of products ...

Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of ...

The CDSCO has also identified 67 additional medications that were classified as Not of Standard Quality (NSQ) due to their ...

The Central Drug Regulatory Authority has identified four drugs, including popular calcium supplement Shelcal 500 and Pan D, as spurious. Additionally, 49 drug samples were deemed "Not of Standard ...

In addition to these, the list featured Metformin tablets ... drugs as “spurious,” including commonly prescribed medications like Shelcal 500, a popular calcium supplement, Pan D, an antacid, Urimax-D ...

Urimax D for Benign Prostate Hyperplasia (BPH), and Deca-Durabolin 25 Injection for osteoporosis in postmenopausal women. The CDSCO's latest report also listed 18 drugs as Not of Standard Quality ...

The purpose of displaying the NSQ list is to make stakeholders aware about the NSQ batches identified in the market, the drug regulator stated. (Image Credits: Pixabay) The Central Drugs Standard ...

Other drugs flagged as spurious in CDSCO’s recent monthly update for September include Urimax D, used to treat Benign Prostate Hyperplasia (BPH) or enlargement of the prostate gland and Deca-Durabolin ...